Usefulness of glycated albumin level as a glycemic index complementing glycosylated hemoglobin in diabetic children and adolescents
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Glycated albumin (GA) is a glycemic marker reflecting the average serum glucose of the previous 2 weeks. This study aimed to evaluate the usefulness of GA as a glycemic index to complement glycosylated hemoglobin (HbA1c) in children and adolescents. Methods: Fifty-four children and adolescents with diabetes mellitus (DM) and 97 children and adolescents without DM (NDM) were enrolled. The correlation between mean blood glucose (MG) and GA compared to HbA1c was investigated in the DM group. The correlation between fasting glucose (FG) and GA compared to HbA1c was investigated in the NDM group. Factors affecting GA, HbA1c, and GA/HbA1c were analyzed. Results: In the DM group, positive correlations were observed between MG and GA (P=0.003), between MG and HbA1c (P=0.001), and between GA and HbA1c (P<0.001). The correlation coefficient between MG and GA did not differ from that between MG and HbA1c in the DM group (P=0.811). Among patients with DM, those whose standardized body mass index standard deviation score (BMI SDS) was ≥2 had a lower GA/HbA1c compared with those whose BMI SDS was <2 (P=0.001). In the NDM group, there were no significant correlations between FG and GA, between FG and HbA1c, or between GA and HbA1c. The NDM subjects whose BMI SDS was ≥2 had a lower GA/HbA1c than did the NDM subjects whose BMI SDS was <2 (P=0.003). Conclusion: GA is comparable with HbA1c in reflecting glycemic control in children and adolescents with DM. GA is affected by obesity in children and adolescents with or without DM.
Abstract
Purpose: Glycated albumin (GA) is a glycemic marker reflecting the average serum glucose of the previous 2 weeks. This study aimed to evaluate the usefulness of GA as a glycemic index to complement glycosylated hemoglobin (HbA1c) in children and adolescents. Methods: Fifty-four children and adolescents with diabetes mellitus (DM) and 97 children and adolescents without DM (NDM) were enrolled. The correlation between mean blood glucose (MG) and GA compared to HbA1c was investigated in the DM group. The correlation between fasting glucose (FG) and GA compared to HbA1c was investigated in the NDM group. Factors affecting GA, HbA1c, and GA/HbA1c were analyzed. Results: In the DM group, positive correlations were observed between MG and GA (P=0.003), between MG and HbA1c (P=0.001), and between GA and HbA1c (P<0.001). The correlation coefficient between MG and GA did not differ from that between MG and HbA1c in the DM group (P=0.811). Among patients with DM, those whose standardized body mass index standard deviation score (BMI SDS) was ≥2 had a lower GA/HbA1c compared with those whose BMI SDS was <2 (P=0.001). In the NDM group, there were no significant correlations between FG and GA, between FG and HbA1c, or between GA and HbA1c. The NDM subjects whose BMI SDS was ≥2 had a lower GA/HbA1c than did the NDM subjects whose BMI SDS was <2 (P=0.003). Conclusion: GA is comparable with HbA1c in reflecting glycemic control in children and adolescents with DM. GA is affected by obesity in children and adolescents with or without DM.
참고문헌 (41)
- Selvin E, "Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults", N Engl J Med, 362, pp.800~811 (2010)
- Zoungas S, "Association of HbA1c levels with vascular complications and death in patients with type 2diabetes : evidence of glycaemic thresholds", Diabetologia, 55, pp.636~643 (2012)
- Goldstein DE, "Tests of glycemia in diabetes", Diabetes Care, 27, pp.1761~1773 (2004)
- Koga M, "Glycated albumin; clinical usefulness", Clin Chim Acta, 433, pp.96~104 (2014)
- Virtue MA, "Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration", Diabetes Care, 27, pp.931~935 (2004)
- Bergman M, "Review of methods for detecting glycemic disorders", Diabetes Res Clin Pract, 165, pp.108233~ (2020)
- Neelofar K, "An overview of in vitro and in vivo glycation of albumin : a potential disease marker in diabetes mellitus", Glycoconj J, 34, pp.575~584 (2017)
- Inaba M, "Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes : effect of anemia and erythropoietin injection", J Am Soc Nephrol, 18, pp.896~903 (2007)
- Roohk HV, "A review of glycated albumin as an intermediate glycation index for controlling diabetes", J Diabetes Sci Technol, 2, pp.1114~1121 (2008)
- Koga M, "Clinical impact of glycated albumin as another glycemic control marker", Endocr J, 57, pp.751~762 (2010)
- Koga M, "Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia", Clin Chim Acta, 412, pp.253~257 (2011)
- Anguizola J, "Review : glycation of human serum albumin", Clin Chim Acta, 425, pp.64~76 (2013)
- Yazdanpanah S, "Evaluation of glycated albumin(GA)and GA", HbA1c ratio for diagnosis of diabetes and glycemic control : a comprehensive review, 2017, pp.54, 219~232
- Takahashi S, "Comparison of glycated albumin(GA)and glycated hemoglobin(HbA1c)in type 2 diabetic patients : usefulness of GA for evaluation of short-term changes in glycemic control", Endocr J, 54, pp.139~144 (2007)
- Yoshiuchi K, "Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes", Endocr J, 55, pp.503~507 (2008)
- Lee EY, "Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients", Acta Diabetol, 48, pp.167~172 (2011)
- Wang BR, "Association of glycated albumin", glycosylated hemoglobin ratio with blood glucose fluctuation and long-term blood glucose control in patients with type 2 diabetes mellitus, 2021, pp.14, 1809~1815
- Sumner AE, "A1C combined with glycated albumin improves detection of prediabetes in Africans : the Africans in America study", Diabetes Care, 39, pp.271~277 (2016)
- Sumner AE, "Glycated albumin identifies prediabetes not detected by hemoglobin A1c : the Africans in America study", Clin Chem, 62, pp.1524~1532 (2016)
- 이지우, "Serum glycated albumin as a new glycemic marker in pediatric diabetes", Annals of Pediatric Endocrinology & Metabolism, 18(4), pp.208~213 (2013), 대한소아내분비학회
- Chan CL, "Screening for type 2 diabetes and prediabetes in obese youth : evaluating alternate markers of glycemia-1, 5-anhydroglucitol, fructosamine, and glycated albumin", Pediatr Diabetes, 17, pp.206~211 (2016)
- Chan CL, "Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes", Pediatr Diabetes, 18, pp.629~636 (2017)
- 김재현, "The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects", Clinical and Experimental Pediatrics, 61(5), pp.135~149 (2018), 대한소아청소년과학회
- Paroni R, "Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma", Clin Biochem, 40, pp.1398~1405 (2007)
- Koga M, "Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients", Endocr J, 53, pp.387~391 (2006)
- Nishimura R, "Glycated albumin is low in obese, nondiabetic children", Diabetes Res Clin Pract, 71, pp.334~338 (2006)
- Miyashita Y, "Glycated albumin is low in obese, type 2diabetic patients", Diabetes Res Clin Pract, 78, pp.51~55 (2007)
- Don BR, "Serum albumin : relationship to inflammation and nutrition", Semi Dial, 17, pp.432~437 (2004)
- 김지은, "Role of obesity-induced inflammation in the development of insulin resistance and type 2 diabetes: history of the research and remaining questions", Annals of Pediatric Endocrinology & Metabolism, 26(1), pp.1~13 (2021), 대한소아내분비학회[DOI]
- Maruo S, "Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes", Diabetol Int, 11, pp.368~375 (2020)
- Gan T, "The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease : progress and challenges", J Diabetes Complications, 32, pp.876~884 (2018)
- Kim D, "The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function", Clin Endocrinol(Oxf), 77, pp.679~683 (2012)
- Saisho Y, "Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2diabetes", Endocr J, 61, pp.149~157 (2014)
- Koga M, "Serum glycated albumin to haemoglobin A1c ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus", Ann Clin Biochem, 47, pp.313~317 (2010)
- Koga M, "Evaluation of the glycated albumin", HbA1c ratio by stage of diabetic nephropathy, 2011, pp.2, 141~145
- Wang N, "Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus", Diabetes Metab Res Rev, 33(2) (2017)[DOI]
- Umayahara Y, "Association of glycated albumin to HbA1c ratio with diabetic retinopathy but not diabetic nephropathy in patients with type 2 diabetes", Clin Biochem, 50, pp.270~273 (2017)
- Ceriello A, "Glycaemic variability in diabetes : clinical and therapeutic implications", Lancet Diabetes Endocrinol, 7, pp.221~230 (2019)
- Pan J, "Influence of insulin sensitivity and secretion on glycated albumin and hemoglobin A1c in pregnant women with gestational diabetes mellitus", Int J Gynaecol Obstet, 121, pp.252~256 (2013)
- Desouza CV, "Glycated albumin at 4 weeks correlates with A1c levels at 12 weeks and reflects short-term glucose fluctuations", Endocr Pract, 21, pp.1195~1203 (2015)
- Ogawa A, "New indices for predicting glycaemic variability", PLoS One, 7, pp.e46517~ (2012)